BMLKF.US BML, Inc.

Healthcare Diagnostics & Research USA Stocks
25.21 USD
Close of Nov 13, 2026
19.36 25.21
Market cap
USD 945M
P/E
19.1x
P/B
0.90x
ROE
6.2%
Dividend yield
3.19%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is BMLKF.US undervalued?

Graham number
Price25.21
Graham value28.92
Discount12.8%

BMLKF.US trades 12.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BML, Inc. fundamental analysis

No fundamental analysis for BML, Inc. yet.

BML, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BML, Inc.

BML, Inc. provides contract clinical testing and related services in Japan. The company offers routine laboratory testing, such as biochemical and hematologic examination; special laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony a…

Full company profile